CN1183962A - 痤疮灵药水 - Google Patents

痤疮灵药水 Download PDF

Info

Publication number
CN1183962A
CN1183962A CN 97114483 CN97114483A CN1183962A CN 1183962 A CN1183962 A CN 1183962A CN 97114483 CN97114483 CN 97114483 CN 97114483 A CN97114483 A CN 97114483A CN 1183962 A CN1183962 A CN 1183962A
Authority
CN
China
Prior art keywords
gram
liquid medicine
acne
diethylstilbestrol
tween
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97114483
Other languages
English (en)
Inventor
曾爱萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97114483 priority Critical patent/CN1183962A/zh
Publication of CN1183962A publication Critical patent/CN1183962A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明涉及一种痤疮药水,是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括:甲硝唑、乙底酚、甲氰米胍、维A酸、硼酸粉。本发明用于治疗痤疮,疗效好,且用后患处不留疤痕,无任何副作用。

Description

痤疮药水
本发明涉及一种外搽药水,确切地说是一种痤疮药水。
痤疮是一种常见的多发病,人们特别是青年人患后不仅影响工作、学习,而且有损美貌。为了治疗这种病,目前人们已研制出多种外用药,虽有一定疗效,但因都为霜剂或膏剂,搽在患处常易将毛囊孔阻塞,影响体内渗出物的排泄,从而影响药物吸收,疗效差。
本发明的目的提供一种疗效好,用后患处不留疤痕且无任何不适感的痤疮药水。
本发明的目的是由以下技术方案实现的。
本发明是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括;甲硝唑,乙底酚、甲氰米胍、维A酸、硼酸粉。
药水配方为
氮铜                    0.3~1%
吐温-80                   0.3~1%
甲硝唑                    0.5~1%
乙底酚                    0.004~0.01%
甲氰米胍                  0.5~3%
维A酸                     0.5~2%
硼酸粉                    0.5~1%
本发明的优点是由于甲氰咪胍具有抗雄性激素作用,从而可控制皮脂腺活性减少皮脂的产生,减少毛囊管腔的角化物堆积;乙底粉具有增进女性激素的作用;甲硝唑具有较强的杀灭和抑制厌氧菌作用,因此用其配制的药水疗效好且治愈后无疤痕,无任何付作用。
本发明的另一优点是配制简单,成本低廉,利于推广。
以下通过实施例,对本发明作进一步地描述。
实施例1:
取1毫升氮铜和1毫升吐温-80,将其混合研磨乳化后添加0.5克甲硝唑,0.006克乙底酚,0.5克甲氰米胍,0.5克维A酸,0.5克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例2:
取0.3毫升氮铜和0.3毫升吐温-80,将其混合研磨乳化后添加1克甲硝唑,0.004克乙底酚,3克甲氰米胍,2克维A酸,1克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例3:
取0.6毫升氮铜和0.6毫升吐温-80,将其混合研磨乳化后添加0.7克甲硝唑,0.01克乙底酚,2克甲氰米胍,1克维A酸,0.8克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例4:
取0.8毫升氮铜和0.8毫升吐温-80,将其混合研磨乳化后添加0.8克甲硝唑,0.004克乙底酚,2克甲氰米胍,1克维A酸,0.8克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。

Claims (2)

1、一种痤疮药水,是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括:甲硝唑、乙底酚、甲氰米胍、维A酸、硼酸粉。
2、根据权利要求1所述的痤疮药水,其特征在于:所述的药水配方为
氮铜              0.3~1%
吐温-80             0.3~1%
甲硝唑              0.5~1%
乙底酚              0.004~0.01%
甲氰米胍            0.5~3%
维A酸               0.5~2%
硼酸粉              0.5~1%
CN 97114483 1997-08-28 1997-08-28 痤疮灵药水 Pending CN1183962A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97114483 CN1183962A (zh) 1997-08-28 1997-08-28 痤疮灵药水

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97114483 CN1183962A (zh) 1997-08-28 1997-08-28 痤疮灵药水

Publications (1)

Publication Number Publication Date
CN1183962A true CN1183962A (zh) 1998-06-10

Family

ID=5172983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97114483 Pending CN1183962A (zh) 1997-08-28 1997-08-28 痤疮灵药水

Country Status (1)

Country Link
CN (1) CN1183962A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090936C (zh) * 1999-05-19 2002-09-18 张广政 一种治疗痤疮的复合制剂
WO2012001338A1 (en) * 2010-07-01 2012-01-05 Kartar Singh Lalvani Composition for the treatment of acne vulgaris

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090936C (zh) * 1999-05-19 2002-09-18 张广政 一种治疗痤疮的复合制剂
WO2012001338A1 (en) * 2010-07-01 2012-01-05 Kartar Singh Lalvani Composition for the treatment of acne vulgaris

Similar Documents

Publication Publication Date Title
EP0787005B1 (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
US6071543A (en) Pyridine-thiols reverse mucocutaneous aging
EP1047399B1 (en) Skin care composition
US6667045B2 (en) Topical applications for skin treatment
US5710141A (en) Method for treating skin wrinkles
EP2286809A1 (en) Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin
US20060013845A1 (en) Oxygenated personal care products
CN109745261B (zh) 一种头皮护理液及其制备方法
EP1565189A1 (en) Anti-aging skin care composition and uses thereof
US20060024339A1 (en) Methods of managing the redness associated with a dermatological condition
WO2003026639A1 (en) Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
IL129272A (en) Preparation for the treatment and treatment of skin damage and its preparation
PH12009000168A1 (en) Stabilized compositions containing an oxygen-labile active agent
CN113134088B (zh) 一种含有生物多糖的组合物及其应用
CN101489541A (zh) 多胺在治疗银屑病中的应用
US20030165577A1 (en) Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
KR20110074513A (ko) 피부 감염의 국소 치료법
CA2776702A1 (en) Topical dapsone for the treatment of acne
JP2000038340A (ja) 育毛剤および食品
Happle et al. Systemic retinoid therapy of systematized verrucous epidermal nevus
CN1183962A (zh) 痤疮灵药水
CN103479661B (zh) 一种祛痘美容药
US7198807B2 (en) Inhibition of P. acnes using botanical extracts
US5240945A (en) Method and compositions for treating acne
KR100202058B1 (ko) 혼합미백제 조성물

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication